Stock PHRX PHARMADRUG INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharmadrug Inc.

Equities

PHRX

CA71716W2040

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 03:21:59 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.03 CAD 0.00% Intraday chart for Pharmadrug Inc. 0.00% -45.45%
Apr. 16 PharmaTher Updated on its Priority Original Abbreviated New Drug Application for Ketamine MT
Mar. 13 Pharmadrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 7.768 2.083 15.76 11.93 5.334
Enterprise Value (EV) 1 8.573 5.131 12.48 11.5 6.428
P/E ratio -0.88 x -0.28 x -2.18 x -2.06 x -0.59 x
Yield - - - - -
Capitalization / Revenue - 3,410,806 x 23,052,644 x 24,098,557 x -
EV / Revenue - 8,403,103 x 18,257,159 x 23,231,869 x -
EV / EBITDA - -1,196,159 x -4,906,403 x -3,003,751 x -3,616,747 x
EV / FCF -8.2 x -4.18 x -10.2 x -7.4 x -6.3 x
FCF Yield -12.2% -23.9% -9.82% -13.5% -15.9%
Price to Book -15.8 x 0.7 x 2.07 x 0.71 x 0.6 x
Nbr of stocks (in thousands) 4,439 11,900 28,144 48,688 50,804
Reference price 2 1.750 0.1750 0.5600 0.2450 0.1050
Announcement Date 4/30/19 6/15/20 4/30/21 5/3/22 5/12/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales - - 0.6106 0.6837 0.495 -
EBITDA - - -4.289 -2.544 -3.828 -1.777
EBIT 1 -0.7953 -0.9299 -5.041 -3.799 -5.047 -2.356
Operating Margin - - -825.6% -555.69% -1,019.59% -
Earnings before Tax (EBT) 1 -1.155 -3.512 -6.982 -5.903 -6.707 -3.254
Net income 1 -1.155 -3.886 -6.29 -5.219 -5.626 -8.876
Net margin - - -1,030.15% -763.38% -1,136.69% -
EPS 2 -0.4886 -1.978 -0.6280 -0.2565 -0.1189 -0.1790
Free Cash Flow 1 -0.1011 -1.046 -1.227 -1.226 -1.554 -1.02
FCF margin - - -200.9% -179.38% -313.92% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 5/31/18 4/30/19 6/15/20 4/30/21 5/3/22 5/12/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 0.53 0.81 3.05 - - 1.09
Net Cash position 1 - - - 3.28 0.43 -
Leverage (Debt/EBITDA) - - -0.7106 x - - -0.6152 x
Free Cash Flow 1 -0.1 -1.05 -1.23 -1.23 -1.55 -1.02
ROE (net income / shareholders' equity) 1,018% 620% -330% -73.4% -42.3% -23.8%
ROA (Net income/ Total Assets) -61.2% -58.1% -55.1% -19.7% -19% -9.31%
Assets 1 1.887 6.683 11.42 26.45 29.62 95.35
Book Value Per Share 2 -0.2700 -0.1100 0.2500 0.2700 0.3500 0.1700
Cash Flow per Share 2 0.2100 0.0300 0.0100 0.0600 0.0200 0
Capex - - 0.01 0.02 - -
Capex / Sales - - 1.6% 2.63% - -
Announcement Date 5/31/18 4/30/19 6/15/20 4/30/21 5/3/22 5/12/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
PHARMADRUG INC. Stock Pharmadrug Inc.
-45.45% 2.29M
MCKESSON CORPORATION Stock McKesson Corporation
+15.79% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.09% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-2.59% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.95% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.48% 7.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+15.26% 4.31B
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 3.93B
GALENICA AG Stock Galenica AG
-3.02% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.10% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. PHRX Stock
  4. Financials Pharmadrug Inc.